What question did this study set out to answer?

The aim is to explore the genomic characteristics of high-grade serous ovarian carcinoma and their implications for treatment.

High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions

View Full Paper

Ask AI

Bookmark

Authors

This review highlights genomic profiling's role in improving outcomes for ovarian cancer via novel therapies and approaches.

The aim is to explore the genomic characteristics of high-grade serous ovarian carcinoma and their implications for treatment.
Analysis of next-generation sequencing technologies
Characterization of TP53 mutations and chromosomal instability
Integration of multi-omics approaches including transcriptomics and proteomics
Exploration of AI technology and CRISPR for targeted therapies.
Identified TP53 mutations as a common feature in HGSOC
Revealed homologous recombination deficiency as a therapeutic target
Highlighted challenges due to intratumoural heterogeneity
Supported the use of platinum-based therapies and PARP inhibitors in treatment.

Lewis et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark